Interventions to combat or prevent drug counterfeiting: a systematic review

BMJ Open
Fadi El-JardaliRasha Hamra

Abstract

Drug counterfeiting has serious public health and safety implications. The objective of this study was to systematically review the evidence on the effectiveness of interventions to combat or prevent drug counterfeiting. We searched multiple electronic databases and the grey literature up to March 2014. Two reviewers completed, in duplicate and independently, the study selection, data abstraction and risk of bias assessment. We included randomised trials, non-randomised studies, and case studies examining any intervention at the health system-level to combat or prevent drug counterfeiting. Outcomes of interest included changes in failure rates of tested drugs and changes in prevalence of counterfeit medicines. We excluded studies that focused exclusively on substandard, degraded or expired drugs, or that focused on medication errors. We assessed the risk of bias in each included study. We reported the results narratively and, where applicable, we conducted meta-analyses. We included 21 studies representing 25 units of analysis. Overall, we found low quality evidence suggesting positive effects of drug registration (OR=0.23; 95% CI 0.08 to 0.67), and WHO-prequalification of drugs (OR=0.06; 95% CI 0.01 to 0.35) in reducing the pr...Continue Reading

References

Feb 3, 2005·Pharmacy World & Science : PWS·Lamphone SyhakhangGöran Tomson
Jun 13, 2006·Transactions of the Royal Society of Tropical Medicine and Hygiene·C T LonA Smine
Aug 25, 2006·American Journal of Law & Medicine·Bryan A Liang
Sep 16, 2006·BMJ : British Medical Journal·Joseph LauIngram Olkin
Jun 7, 2007·The Journal of Antimicrobial Chemotherapy·Theodore KelesidisMatthew E Falagas
May 29, 2008·Malaria Journal·Maike TipkeOlaf Müller
May 1, 2010·Bulletin of the World Health Organization
Jul 1, 2010·Asia-Pacific Journal of Public Health·Michiyo Higuchi
Jun 29, 2010·Journal of Hospital Marketing & Public Relations·Alberto CoustassePhil Rutsohn
Jul 14, 2010·BMC Infectious Diseases·Usman HadiUNKNOWN Study Group Antimicrobial Resistance in Indonesia: Prevalence and Prevention AMRIN
Oct 5, 2010·Pharmaceutical Research·Mohiuddin Hussain KhanKazuko Kimura
Jul 26, 2011·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Aug 2, 2011·Journal of Clinical Epidemiology·Gordon H GuyattUNKNOWN GRADE Working Group
Sep 16, 2011·Journal of Health Economics·Roger BateAparna Mathur
Dec 14, 2011·PLoS Medicine·Paul N NewtonNicholas J White
May 29, 2012·The Lancet Infectious Diseases·Gaurvika M L NayyarJames Herrington
Jul 14, 2012·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Jonathan Liberman
Nov 15, 2012·BMJ : British Medical Journal·Amir AttaranMartin McKee
Jan 17, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·R BateJ Milligan
Feb 7, 2013·Journal of Pharmaceutical and Biomedical Analysis·Klara DégardinPierre Margot
May 4, 2013·Scientia pharmaceutica·Dipika BansalPramil Tiwari
Aug 21, 2013·BMJ Open·Tariq AlmuzainiHelen Sammons
Oct 16, 2013·Health Research Policy and Systems·Maryam BigdeliUNKNOWN Alliance for Health Policy and Systems Research Network of Researchers on Access to Medicines
Apr 1, 2010·Research Synthesis Methods·Michael BorensteinHannah R Rothstein
Jul 17, 2015·Journal of Public Health Policy·Ellen 't Hoen, Fernando Pascual
Nov 10, 2015·Bulletin of the World Health Organization·Linda BartlettUNKNOWN Quality of Maternal and Newborn Care Study Group of the Maternal and Child Health Integrated Program
Oct 26, 2011·Nursing Older People·Ruth Williams

❮ Previous
Next ❯

Citations

Jul 15, 2015·Systematic Reviews·Etienne V LangloisJohn-Arne Røttingen
Aug 24, 2017·The International Journal of Pharmacy Practice·Lydia SholyAngela MacAdam
Aug 18, 2018·Drug Development and Industrial Pharmacy·Julie Babyar
Sep 13, 2017·The Cochrane Database of Systematic Reviews·Cristian A HerreraAndrew D Oxman
Feb 14, 2019·PloS One·Elizabeth Thithi NdichuKevin Schulman
May 22, 2020·BMC Public Health·Daariimaa KhurelbatBaasandorj Erdenetsetseg
May 31, 2020·Journal of the American Pharmacists Association : JAPhA·C Michael White
Sep 10, 2018·The Lancet Global Health·Margaret E KrukMuhammad Pate

❮ Previous
Next ❯

Software Mentioned

Opengrey
Academic Search Complete
PROSPERO
Health
RevMan
Cab
Google Scholar
Mednar
GreylitNetwork

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.